The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
- collapse A randomised, double blinded, multicentre phase II study to assess the efficacy of olaparib (AZD2281, KU-0059436) in combination with paclitaxel
- collapse A Randomised, Double-blind, Placebo-controlled, Three-way Cross-over Single Center Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)
- collapse A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD1208 in Patients With Advanced Solid Malignancies Including Malignant Lymphoma.
- collapse Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA.
- collapse LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
- collapse Study of cases and controls on diagnosis and treatment strategies in patients with NSCLC with or without EGFR mutations.
- collapse Observational Study on the Management of Patients With Non Small Cell Lung Cancer (NSCLC) Adenocarcinoma Tested for the Activating Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase
- collapse ZD6474 and Docetaxel in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- collapse ZD6474 in Treating Patients With Small Cell Lung Cancer
- collapse A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTRE, PHASE II STUDY TO EVALUATE THE SAFETY AND PHARMACOLOGICAL ACTIVITY OF THE COMBINATION OF VANDETANIB (100 OR 300 MG/DAILY OR PLACEBO) WITH FULVESTRANT (LOADING DOSE), IN POSTMENOPAUSAL ADVANCED BREAST CANCER PATIENTS.
